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Abstract
Background: Ethanol is the most widely used drug in the world and a human teratogen whose consumption among
women of childbearing age has been steadily increasing. There are no Italian or Spanish statistics on ethanol
consumption during pregnancy nor any information regarding prevalence of fetal alcohol syndrome (FAS) and fetal
alcohol spectrum disorders (FASD). There is also a reasonable suspicion that these two diseases are underdiagnosed by
professionals from the above-reported countries. The objectives of this study were: 1) to evaluate the experience,
knowledge and confidence of Italian and Spanish neonatologists and paediatricians with respect to the diagnosis of
FAS and FASD, and 2) to evaluate professionals awareness of maternal drinking patterns during pregnancy.
Methods: A multiple-choice anonymous questionnaire was e-mailed to Italian neonatologists registered in the
mailing list of the corresponding Society and administered to Italian and Spanish paediatricians during their
National Congress.
Results: The response rate was 16% (63/400) for the Italian neonatologists of the National Society while a total of
152 Spanish and 41 Italian paediatricians agreed to complete the questionnaire during National Congress. Over
90% of the surveyed physicians declared that FAS is an identifiable syndrome and over 60% of them identified at
least one of the most important features of FAS. Although over 60% Italian responders and around 80% Spanish
responders were aware that ethanol use in pregnancy is dangerous, approximately 50% Italian responders and 40%
Spanish ones allowed women to drink sometimes a glass of wine or beer during pregnancy.
Neonatologists and paediatricians rated confidence in the ability to diagnosis FAS and FASD as low, with over 50%
responders feeling they needed more information regarding FAS and FASD identification in newborn and child.
Conclusions: Italian and Spanish neonatologists and paediatricians do not feel confident about diagnosing FAS
and FASD. More training is needed in order to accurately diagnose ethanol use during pregnancy and correctly
inform pregnant women on the consequences on the newborn.
Background
Italy and Spain are two Mediterranean countries which,
due to their position in Europe, are the centre of both
industrial and cultural vitality, attracting tourists, busi-
ness people and immigrants. In the past 20 years, the
lifestyles of the Italian and Spanish population have
changed radically, especially those of women, who have
adopted behaviour models traditionally associated with
men. Among the most important changes there has
been the increasing number of women who smoke, and
more recently, who drink, reflecting their changing role
in the society [1].
The available data from the most recent Italian
National Surveys on use and abuse of alcohol show that
the percentage of women of childbearing age who
* Correspondence: federica.vagnarelli@asmn.re.it
1Arcispedale Santa Maria Nuova NICU, Reggio Emilia, Italy
Full list of author information is available at the end of the article
Vagnarelli et al. BMC Pediatrics 2011, 11:51
http://www.biomedcentral.com/1471-2431/11/51
© 2011 Vagnarelli et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
declare daily intake of any alcoholic drink is around 7%
between 18 and 44 years of age respectively while that
of risky consumers (those who declare to exceed the
daily ethanol dose of 20 g) is 6.8 and 4.6% at 18-24 and
25-44 years of age, respectively [1,2]. Concerning Span-
ish women, the percentage who declare daily intake of
any alcoholic drink ranged between 1-2% at 15-34 years
of age, increasing to 5.1% at 35-44 years of age [3].
Binge drinking is declared by the 13-15% Spanish
women of childbearing age and the rate of excessive
Spanish drinkers (excessive drinking was defined as con-
sumption of more than 700 ml of pure ethanol per
week) was reported for the 0.2% Spanish women[3,4].
Consequently, it is conceivable that a significant num-
ber of women who are problem drinkers and are of
child bearing age, will not refrain from ethanol drinking
during pregnancy and may give birth to an infant in
utero exposed to this toxin. Since prenatal exposure to
ethanol has been considered one of the principal diag-
nostic criteria (or the principal itself) for fetal alcohol
syndrome (FAS) and fetal alcohol spectrum disorder
(FASD), an early postnatal objective diagnosis by meco-
nium testing for fatty acid ethyl esters (FAEEs) and
ethyl glucuronide associated to clinical and neurological
follow-up of exposed newborns has been suggested
[5-7]. However, universal neonatal screening by meco-
nium testing of alcohol biomarkers is, at moment, too
expensive in terms of laboratory facilities and skilled
personnel to be performed.
Indeed, there are no Italian or Spanish national data
on FAS/FASD prevalence, no national clinical protocols
for FAS/FASD diagnosis and finally no national cohort
studies. The only Italian experience of a field study,
aimed to assess the prevalence of FAS and FASD by ret-
rospective cohort study in a restricted area of Rome
province (Lazio region). This study, conducted on 543
children from primary schools showed a striking FAS
and FADS prevalence of 0.37 and 2.3% examined chil-
dren raising the question of whether FASD is more
common in the Mediterranean countries than previously
estimated [8].
Most of the research on the prevalence of FAS and
FASD comes from North America [9,10]; nevertheless, a
Canadian study has documented that, due to lack of
training, a substantial number of physicians do not feel
comfortable in making a diagnosis of FAS [11]. Simi-
larly, an American survey confirmed that pediatricians
are knowledgeable about fetal alcohol syndrome but do
not feel adequately trained to integrate the management
of this diagnosis or prevention efforts into everyday
practice [12]. A recent Israeli study [13] corroborated
this latter statement demonstrating that those physicians
who are at the forefront of diagnosing, treating and pre-
venting FAS and FASD surprisingly declared their
limited experience in dealing with the issue in a practi-
cal way. Finally, also Australian health professionals
dealing with FAS and FASD identified in two subse-
quent surveys the need for educational materials for
themselves and their clients [14,15].
These differences in opinion and inability to diagnosis
FAS and FASD may reflect inadequacies in medical train-
ing regarding ethanol use and abuse during pregnancy
and more specifically about these patterns of mental and
physical defects caused by in utero exposure to the toxin.
Since recently an Italian-Spanish joint research group
disclosed an alarming prevalence of fetal ethanol exposure
in Barcelona, Spain and more recently in Rome and Reggio
Emilia, Italy by meconium testing [16,7], the same group
sought to evaluate awareness of the diagnosis of FAS and
FASD and maternal alcohol use during pregnancy in Ita-
lian and Spanish neonatologists and paediatricians.
Methods
The self-administered questionnaire was e-mailed to the
400 Italian neonatologists members of the Italian Society
of Neonatology, SIN, by the Society secretary. The first
contact was in June 2010 by e-mail. A second and a
third e-mail were sent if no answers were received
within a month. Finally, a telephone call was made to
the neonatologists, who did not answer even to the
third mail.
In order to also evaluate the know-how of paediatri-
cians, the same questionnaire was proposed to partici-
pants to a special sessions dedicated to diagnosis of FAS
and FASD and maternal ethanol use during pregnancy
at the 66th Italian Paediatric Congress (Rome 20-23
October 2010), and during the First Spanish Congress
on “Drugs of Abuse and Pregnancy” (Murcia, 15-16 Sep-
tember 2010). Questionnaire was distributed and col-
lected, once completed, by Congress Hostesses before
the start of the sessions.
The individual identifiers of the questionnaires were
stripped once the surveys had been received and that all
data held were treated as being confidential.
The questionnaire was the Italian adapted version of
questionnaire submitted to the family physicians by the
Canadian investigators on FASD [11], with some of
which our Italian-Spanish investigation group has been
worked since many years.
It was five-pages long consisting of multiple choice
questions. There were sixteen questions that were
divided into three sections: 1) epidemiology of the pro-
blem, 2) identification of newborns at risk and the ability
to diagnose FAS and FASD indicating key factors in the
diagnosis making, 3) identification of mothers at risk, or
the ability to identify factors related to problem drinking
in pregnant women by asking which tools they use for
the assessment of ethanol use. This last section was
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introduced to investigate the ability of professionals to
identify factors related to problematic drinking in preg-
nant women, by asking them which tools they use or sug-
gest together with gynaecologists and nurses for the
assessment of maternal ethanol use during pregnancy.
The questionnaire and the study were approved by the
Institutional Ethical Committee of Istituto Superiore di
Sanità, conducted in accordance with the Declaration of
Helsinki and signed informed consent was obtained
from all the neonatologists and paediatricians, who com-
pleted the questionnaires.
Since this was an exploratory survey of neonatologists
and paediatricians awareness of the diagnosis of FAS
and FASD and maternal ethanol use during pregnancy,
descriptive statistics in numbers and percentages were
used to present the results. Confidence interval at 95%
(C.I. 95%) for the proportions using the Wald’s con-
struction, with an alpha = 0.05 was also calculated.
Results
A total of 63/400 (16%) Italian neonatologists, 41 Italian
and 152 Spanish paediatricians (100% of the participants
to the above-reported sessions during national paediatric
Congresses) returned the completed questionnaires.
The first three questions asked were: “in Italy/Spain
the percentage of pregnant women consuming ethanol
1)any time, 2) daily or 3) problematically is a) unknown
because never studied, b) unknown because impossible
to estimate, or c) well known (percentage given). Main
results are summarised in Additional File 1. With
regards the percentage of newborns with presumed FAS
or FASD, the majority of Italian neonatologists and pae-
diatricians (over 50% respondents) rated a percentage
while the majority of Spanish paediatricians (over 60%
respondents) answered “unknown because never studied
(Additional File 1).
To assess knowledge regarding FAS and FASD facts in
general, responders were asked to give their opinion on
the accuracy of six statements they had to evaluate. As a
group, the Italian and Spanish respondents agreed that
these statements were accurate (Additional File 1).
The respondents were then asked about identification
of newborns at risk. According to 54% Spanish paedia-
tricians and 60% Italian neonatologists, the identification
of newborns at risk is more accurate analysing neonatal
biomarkers. However, few responders (around 2-3%)
indicated the correct neonatal biomarkers (e.g FAEEs
and ethyl glucuronide in meconium), while the others
listed generic parameters (e.g. gamma GT, carbohydrate
deficient transferrin, alcoholuria).
While 45% Italian paediatricians considered maternal
history (e.g. carbohydrate deficient transferrin, acetalde-
hyde, transaminases) important to study, 35.7% of them
were in favour of neonatal biomarkers.
From a list of FAS associated features, the responders
were asked to select the most important features to aid
the diagnosis. Main results are summarised in Addi-
tional File 1. The responders were next asked to select
most important factors in positively influencing the
quality of life for a child diagnosed with FAS and FASD
from a list which included: actual amount of alcohol
taken by the mother during pregnancy, concomitant
presence of vertically transmitted infection and finally
early diagnosis. About 52% Italian neonatologists, 78%
Italian paediatricians and only 4% Spanish paediatricians
identified the latter as being the most important factor.
In fact the majority of Spanish paediatricians chose the
actual amount of alcohol taken by the mother during
pregnancy
The final question of this section dealt with the physi-
cian’s perceived competency at diagnosing FAS or
FASD, with 55% of the Spanish physicians feeling that
their training was inadequate and 52% of the Italian pae-
diatricians and 64% of the Italian neonatologists feeling
that their training was only in part adequate to diagnose
FAS and FASD.
The last section of the questionnaire aimed to assess
the knowledge of hospital physicians (as referred by the
neonatologists and paediatricians) on the assessment of
ethanol consumption of pregnant women, women who
just delivered and mothers of visited infant. A 59% Ita-
lian neonatologists,78.4% Italian paediatricians and 60%
Spanish paediatricians reported that they always ask the
new mothers about ethanol consumption during preg-
nancy (Additional File 1). Among the responders who
stated that they and their colleagues gynaecologists and
nurses always asked news information on the consump-
tion of ethanol during pregnancy, 90% said they had
obtained such information through general questions.
Just a small minority applied the AUDIT or TWEAK
tests widely used in Anglo-Saxon countries as accurate
screening methods (Additional File 1). In addition, to
identify women at risk, responders judged the maternal
clinical history as the key factor followed by maternal
and neonatal biomarkers.
To elicit the recommendations responders would most
likely give to pregnant women regarding the use of etha-
nol during pregnancy, they were asked to select state-
ments on amount of ethanol considered safe during
pregnancy which they felt were appropriate for counsel-
ling. Spanish paediatricians appeared to be the most
strict regarding alcohol use during pregnancy, while Ita-
lian physicians showed a greater flexibility concerning
occasional use of wine and beer (Additional File 1).
Discussion
Overall, this survey confirmed some of the findings
obtained in similar surveys carried out in other
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geographical areas were the issue of the diagnosis of
FAS and FASD and maternal ethanol use during preg-
nancy was faced in the previous decades [11-15].
This is the first survey concerning FASD awareness
among paediatricians and neonatologists in two Medi-
terranean countries, where ethanol use during preg-
nancy and consequent prenatal exposure to this toxin
has emerged as an overwhelming problem by a series of
Italian -Spanish joined investigations [16-21].
One of the important outcomes and a limit of this
survey is that very few neonatologists among the ones
contacted for the survey completed the questionnaire. In
spite of repeated contacts with non-responders to the
first approach, probably this survey was not considered
as important or neonatologist did not feel comfortable
in answering this questionnaire. Email surveys and/or
studies carried out in Canada and US [11,12] of health
care professionals met similar barriers in recruitment.
Conversely all paediatricians participating in the FAS
and ethanol session during the Italian and Spanish Con-
gresses completed the questionnaire but this was a
selected population: likely, only interested people
attended a specific session on this topic.
Generally speaking, responders either Italian or Spanish
based their opinions on percentages of women drinking
during pregnancy and on FAS and FASD newborns pre-
valence on their own perception of the problem since
there are no Italian or Spanish data on these two issues.
In this concern, even if it has been shown that the major-
ity of health professionals in contact with pregnant
women ask for ethanol consumption during pregnancy,
this is made with generic questions which can be easily
circumvented. It is surprising that only 3.6% of Italian
neonatologist and 1.7% of Spanish paediatricians
reported using the TWEAK which is currently consid-
ered the most accurate screening method [22].
Another surprising result is related to identification of
the newborns at risk. Indeed, when diagnostic criteria
for FAS were listed as multiple choice, all the Italian
and the Spanish professionals were able to correctly
identify the principle ones. But then, even though the
majority of Italian neonatologists, Spanish pediatricians
and one third of Italian pediatricians think biomarkers
of neonatal exposure to ethanol as gold standard in
identification of newborns at risk, only few of them
were able to properly identify them.
It has to be taken in serious account that although over
60% Italian responders and around 80% Spanish respon-
ders were aware that ethanol use in pregnancy is danger-
ous, approximately 50% Italian responders and 40%
Spanish ones allowed women to drink sometimes a glass
of wine or beer during pregnancy. In addition to that,
responders were not updated on current internationally
established screening methods, such as AUDIT or better
TWEAK tests. It is well known that ethanol crosses the
placenta. It can cause problems during pregnancy and
can also harm the fetus. Whether or not there is any safe
level of ethanol consumption during pregnancy is cur-
rently unknown. Nor it is known if any particular stage
of pregnancy is the most vulnerable to the effects of
drinking [11]. So, in the absence of demonstrated safe
limits, total abstinence from ethanol during pregnancy is
recommended and should be encouraged [23].
A number of limitations to this study should be
mentioned: main one is the relatively small number of
physicians surveyed. Unfortunately, many neonatolo-
gists did not respond to the survey and this can be a
inherent bias, as it is conceivable that the non respon-
ders may be less knowledgeable about FAS and FASD
and therefore not interested or ashamed in filling the
questionnaire. Similarly, all the paediatricians involved
in the survey were the most interested in the issue and
thus the most informed and the most prone to give
the correct answers. Finally, the information would
have been more complete if including obstetricians
and gynaecologists in the survey, which will be the
next step of investigation.
Conclusion
From the answers obtained to all the questionnaire sec-
tion it seems that Italian and Spanish physicians feel
they need more education about FAS and FASD as they
are not confident about being able to make a diagnosis.
The same conclusion was reached also by the previously
reported similar surveys carried out in Canada, US,
Israel and Australia in the recent past [11-15]
Italian and Spanish neonatologists and paediatricians
should better understand the importance of asking preg-
nant women and new mothers about their ethanol use.
Therefore they should be trained about screening meth-
ods to ensure an accurate record which will allow them
to become alerted to women with drinking problem and
consequently to their newborn. Although alcohol is the
most widely consumed teratogen, most of the education
and information in this field is carried out mainly in
North America. Despite abundant alcohol consumption
in Europe, there is no general politics or intervention on
the issue of maternal drinking during pregnancy and
consequent prenatal exposure to this toxin.
Since FAS and FASD are one hundred percent pre-
ventable, neonatologists and paediatricians from Medi-
terranean Countries should receive comprehensive
education in this field, not only to prevent birth of
babies with this syndrome, but also in early detection
which can lead to interventions that can improve the
quality of life of affected children.
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